Have to say though its only the close of 1st week I  too am a  little surpised by the apathy from US investors so far. I expected some postive share price movement and volume interest.

We were told seeing is believing. It was communicated how the OFC was a great success last week from attendees including financiers, analysts and technical experts who viewed the demos. We were also told via media on several occasions notably by Tom, that Institutional were interested in POET  to invest as we stand now but we needed to be on the Nasdaq. So here were are meeting both these objectives and so far this week zilch, snake eyes so far..Hopefully they did not pull a Lucy Charlie Brown manoeuver on us.

What is it going to take to awaken investors to how well positioned we are as a pre revenue company with a miniscule market cap. Based on comparable companies, no way we need to wait for revenue to get this share price moving north and the damm to be opened.

If funds are interested could it be they know it will be difficult to take a significant position on the open market given lack of availalble shares and our low float. Just  looking at the order book all week, not much under 15$. Retail investors are holding strong as they should.  Hopefully something is in the works.

Do we still have more work than anticpated on the burden of proof concept before they take a position on a pre revenue company?.

Perhaps feedback validation from companies participating in beta and alpha samples would do it but how can this be done when we have the NDAs albatross wrapped around our necks.

A bit surprised this week but no doubt some patience needed as we are only closing week 1 on Nasdaq and post OFC.